Literature DB >> 8667419

No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas.

S Ménard, P Casalini, S Pilotti, N Cascinelli, F Rilke, M I Colnaghi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8667419     DOI： 10.1093/jnci/88.14.1002

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53.

Authors:  S W Beenken; W E Grizzle; D R Crowe; M G Conner; H L Weiss; M T Sellers; H Krontiras; M M Urist; K I Bland
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

2.  Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients.

Authors:  Mais M Al-Mumen; Asad A Al-Janabi; Alaa S Jumaa; Kaswer M Al-Toriahi; Akeel A Yasseen
Journal:  BMC Res Notes       Date:  2011-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.